Drug intelligence / Profile preview

Jian Aikang Concentrated Pill

Development stage
Preclinical
Lead developer
First Affiliated Hospital of Henan University of Chinese Medicine
Administration
Oral
01

Overview

**Jian Aikang Concentrated Pill** is an oral traditional Chinese multi-herb medicine formula investigated in China as part of syndrome-differentiated traditional Chinese medicine interventions intended to delay disease progression in people with HIV infection. A registered prospective trial sponsored by The First Affiliated Hospital of Henan University of Chinese Medicine included Jian Aikang Concentrated Pill alongside Yiaikang Capsule and Tangcao Tablet. Preclinical network-pharmacology and HIV-pseudovirus-infected MT-4 cell studies proposed immunomodulatory and anti-inflammatory effects, including modulation of IL-1 alpha and IL-6 expression; however, its specific active ingredients, direct molecular targets, clinical efficacy, regulatory status, and manufacturer were not established by the available public sources. ([chictr.org.cn](https://www.chictr.org.cn/showproj.html?proj=30790))

Other names
JAKCPJian Aikang condensed pillJianaikangJianaikang concentrated pill健艾康浓缩丸
02

Targets

IL-6 (Interleukin 6)IL10 (Interleukin-10)IL1A (Interleukin 1 alpha)IL6ST (Interleukin-6 receptor subunit beta)HSP90AA1 (Heat shock protein HSP90-alpha)TP53 (Cellular Tumor Antigen p53 R175H)IL-2 (Interleukin 2)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Jian Aikang Concentrated Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jian Aikang Concentrated Pill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call